View this email .

American
 Dental Education Association

Volume 2, No. 7, April 27, 2021

ADEA Advocacy in Action

This appears weekly in the ADEA Advocate to summarize and provide direct links to recent advocacy actions taken by ADEA. Please let us know what you think and how we might improve its usefulness.

 

Issues and Resources

  • NHSC Service Loan Repayment Program and application
  • ADEA regarding vaccines at the state level
  • NIH "Understanding and Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities"
  • NIDCR "Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement"
  • For a full list of ADEA memos and letters click .
Kansas Governor Signs Bill to Increase Licensure Reciprocity

 

On April 21, Kansas Gov. Laura Kelly (D) that would increase licensure reciprocity in the state. The new law requires licensing boards in the state, including the Kansas Dental Board, to grant licenses to individuals who:

  • Establish residency in the state or intend to establish residency,
  • Hold a license that is in good standing from another jurisdiction that authorizes a similar scope of practice,
  • Have worked for at least one year in the profession in which the license is sought.

Applicants who meet the requirements would be given a probationary license at least 45 days after submitting a complete application that will allow them to practice. (The period is 15 days for a member of the military or a military spouse.) The probationary period is not permitted to last longer than six months, and upon completion of the probationary period, the license will become a non-probationary license.

 

Additionally, when an applicant has not worked in their occupation for the preceding two years, licensing bodies are permitted to require applicants to complete additional testing, training, monitoring or continuing education to establish the applicant’s ability to practice in a manner that protects the public health and safety.

 

Similar legislation was recently signed by the Governor of , and in recent years, similar laws have been implemented in , and .

Democrats Reintroduce Prescription Drug-pricing Negotiation Bill

 

The U.S. House of Representatives’ Energy and Commerce Committee Chairman Frank Pallone Jr. (D-N.J.), Ways and Means Committee Chairman Richard E. Neal (D-Mass.) and Education and Labor Committee Chairman Robert C. "Bobby" Scott (D-Va.) reintroduced the Elijah E. Cummings Lower Drug Costs Now Act.

 

The Elijah E. Cummings Lower Drug Costs Now Act would lower the cost of prescription drugs by:

  • Allowing the federal government to negotiate the cost of prescription drugs in Medicare and make those negotiated prices available to commercial health insurance plans,
  • Capping Medicare beneficiaries’ out-of-pocket spending on prescription drugs at $2,000 per year,
  • Requiring drug manufacturers to pay a rebate to the federal government if they increase prices faster than inflation and
  • Reinvesting federal cost-savings in the National Institutes of Health and the Food and Drug Administration to support research and development of new breakthrough treatments and cures, as well as making investments in combatting the opioid crisis.

In 2019, the Congressional Budget Office estimated that the price negotiation provisions in the bill would save the federal government $456 billion over 10 years.

CDC Releases Report on Post-vaccine, COVID-19 Infections

 

The Centers for Disease Control and Prevention (CDC) released a report showing that about 5,800 people tested positive for the coronavirus two weeks or more after they completed both doses of the Pfizer-BioNTech or Moderna vaccine.

 

Of these breakthrough infections, 40% were in people ages 60 or older and 65% occurred in women. Of those who tested positive, 29% exhibited no symptoms, 7% were hospitalized and 1%—74 people— died, according to the CDC.

 

The CDC will focus on genetically sequencing samples from patients who test positive for the coronavirus post-vaccination to determine if variants are causing breakthrough cases.

 

A little over 89,000,000 people were fully vaccinated in the United States as of April 23.

New Jersey Governor Signs Bill That Requires Co-prescribing

 

On April 19, New Jersey Gov. Phil Murphy (D) that requires prescribers to co-prescribe under certain circumstances an opioid antidote when prescribing an opioid drug that is a controlled dangerous substance. Under the new law, those certain circumstances are when:

  • A patient has a history of substance use disorder,
  • A prescription is for a daily dose of more than 90 morphine milligram equivalents or
  • A patient holds a current, valid prescription for a benzodiazepine drug that is a Schedule III or IV controlled dangerous substance.

Similar policies have been adopted in in recent years.

State Medicaid Update

 

Recently, several states have made or have been pursing significant changes to their state Medicaid programs. Brief summaries of some of the most significant developments can be found below:

  • In , lawmakers have demonstrated resistance to Medicaid expansion despite a voter-approved referendum requiring the state to expand its program. Earlier this month, the state House of Representatives that was set aside for the expansion to other social welfare programs. Although a compromise was proposed in the state Senate to partially restore the funding, the compromise was rejected by a Senate committee.
  • In , the state House of Representatives recently voted down a plan that would have led to Medicaid expansion. Although recent previous efforts to pass Medicaid expansion failed in the Texas Legislature, proponents hoped this year would be different as a handful of Republicans supported the initiative. Additionally, an , which helps the state reimburse hospitals for uncompensated care, was rescinded by the Biden administration on the grounds that Centers for Medicare & Medicaid Services erred in exempting the state from the normal public notice process before granting the extension.
  • In , legislators voted to keep their Medicaid expansion program for another year. after the state House Representatives voted to reject the funding on several previous occasions.
  • Finally, in , Gov. Kevin Stitt’s (R) plan to privatize the state’s Medicaid system is facing stiff opposition from the state legislature. On April 20, the state House of Representatives that would create a managed care program run by the Oklahoma Health Care Authority instead of private companies. That bill will now be sent to the state Senate for consideration.

The is published weekly. Its purpose is to keep ADEA members abreast of federal and state issues and events of interest to the academic dentistry and the dental and research communities.

 

©2021

American Dental Education Association

655 K Street, NW, Suite 800

Washington, DC 20001

202-289-7201,

twitter
Unsubscribe

B. Timothy Leeth, CPA

ADEA Chief Advocacy Officer

 

Bridgette DeHart, J.D.

ADEA Director of Federal Relations and Advocacy

 

Phillip Mauller, M.P.S.

ADEA Director of State Relations and Advocacy

 

Brian Robinson

ADEA Program Manager for Advocacy and Government Relations

 

Higher Logic